Skip to search formSkip to main contentSkip to account menu

denibulin

A small molecular vascular disrupting agent (VDA), with potential antimitotic and antineoplastic activities. Denibulin selectively targets and… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Benzimidazoles
Denibulin HydrochlorideMicrotubule Process

Narrower (1)

MN-029

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Denibulin di-hydrochloride
MN-029 di-hydrochloride (MN-029.2HC1, Formula 2) is a potent vascular targeting agent. The present invention focuses on the… 
2011
2011
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
PurposeMN-029 (denibulin HCl) is a novel vascular-disrupting agent that reversibly inhibits microtubule assembly, resulting in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)